BDBM273780 US10071079, Example 566::US10478424, Example 566

SMILES: COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1

InChI Key: InChIKey=GVOXRVNGTVSQSA-UHFFFAOYSA-N

Data: 6 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 273780   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Toll-like receptor 7 (Homo sapiens (Human))	BDBM273780 (US10071079, Example 566 | US10478424, Example 566) Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1 Show InChI InChI=1S/C28H35N5O2/c1-18(2)25-22-11-20(19-7-9-32(10-8-19)14-28(3)15-35-16-28)5-6-23(22)31-26(25)21-12-24(34-4)27-29-17-30-33(27)13-21/h5-6,11-13,17-19,31H,7-10,14-16H2,1-4H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.300	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair
Toll-like receptor 8 (Homo sapiens (Human))	BDBM273780 (US10071079, Example 566 | US10478424, Example 566) Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1 Show InChI InChI=1S/C28H35N5O2/c1-18(2)25-22-11-20(19-7-9-32(10-8-19)14-28(3)15-35-16-28)5-6-23(22)31-26(25)21-12-24(34-4)27-29-17-30-33(27)13-21/h5-6,11-13,17-19,31H,7-10,14-16H2,1-4H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair
Toll-like receptor 9 (Homo sapiens (Human))	BDBM273780 (US10071079, Example 566 | US10478424, Example 566) Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1 Show InChI InChI=1S/C28H35N5O2/c1-18(2)25-22-11-20(19-7-9-32(10-8-19)14-28(3)15-35-16-28)5-6-23(22)31-26(25)21-12-24(34-4)27-29-17-30-33(27)13-21/h5-6,11-13,17-19,31H,7-10,14-16H2,1-4H3	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.47E+3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 7 (Homo sapiens (Human))	BDBM273780 (US10071079, Example 566 | US10478424, Example 566) Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1 Show InChI InChI=1S/C28H35N5O2/c1-18(2)25-22-11-20(19-7-9-32(10-8-19)14-28(3)15-35-16-28)5-6-23(22)31-26(25)21-12-24(34-4)27-29-17-30-33(27)13-21/h5-6,11-13,17-19,31H,7-10,14-16H2,1-4H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.300	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 8 (Homo sapiens (Human))	BDBM273780 (US10071079, Example 566 | US10478424, Example 566) Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1 Show InChI InChI=1S/C28H35N5O2/c1-18(2)25-22-11-20(19-7-9-32(10-8-19)14-28(3)15-35-16-28)5-6-23(22)31-26(25)21-12-24(34-4)27-29-17-30-33(27)13-21/h5-6,11-13,17-19,31H,7-10,14-16H2,1-4H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 9 (Homo sapiens (Human))	BDBM273780 (US10071079, Example 566 | US10478424, Example 566) Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2ccc(cc2c1C(C)C)C1CCN(CC2(C)COC2)CC1 Show InChI InChI=1S/C28H35N5O2/c1-18(2)25-22-11-20(19-7-9-32(10-8-19)14-28(3)15-35-16-28)5-6-23(22)31-26(25)21-12-24(34-4)27-29-17-30-33(27)13-21/h5-6,11-13,17-19,31H,7-10,14-16H2,1-4H3	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.47E+3	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair